Dr. Morris is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Physicians Office Building 3 Dr
# 170
Chapel Hill, NC 27599Phone+1 919-483-7282
Education & Training
University of North Carolina HospitalsFellowship, Hematology and Medical Oncology, 2005 - 2008- University of North Carolina HospitalsResidency, Internal Medicine, 2002 - 2005
Case Western Reserve University School of MedicineClass of 2002
Certifications & Licensure
NC State Medical License 2017 - 2025
Publications & Presentations
PubMed
- 26 citationsTrilaciclib prior to chemotherapy reduces the usage of supportive care interventions for chemotherapy-induced myelosuppression in patients with small cell lung cancer:...Renata Ferrarotto, Ian Anderson, Balazs Medgyasszay, Maria Rosario García-Campelo, William Jeffery Edenfield
Cancer Medicine. 2021-09-01 - 411 citationsSafety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trialJeffrey R. Infante, Leslie A. Fecher, Gerald S. Falchook, Sujatha Nallapareddy, Michael S. Gordon
The Lancet. Oncology. 2012-08-01 - 35 citationsA phase I, open-label, two-stage study to investigate the safety, tolerability, pharmacokinetics, and pharmacodynamics of the oral AKT inhibitor GSK2141795 in patients...Carol Aghajanian, Katherine M. Bell-McGuinn, Howard A. Burris, Lillian L. Siu, Lee Ann Stayner
Investigational New Drugs. 2018-04-03
Press Mentions
G1 Therapeutics Makes Key Appointments to Management TeamAugust 3rd, 2017
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
